The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Blanket Purchase Agreement (BPA) to Abbott Laboratories Inc., a major pharmaceutical and medical device company, to provide testing supplies and reagents. The BPA, valued at up to $640,000, is issued against Abbott's existing GSA Schedule 65-VII contract for In Vitro Diagnostics, Reagents, and Tests. Under this agreement, the VA will be able to efficiently procure point-of-care testing devices, related consumables, and quality control materials from Abbott to support veteran healthcare services across its facilities. The contract provides for a base period through September 2026, with individual BPA call orders issued as needed, priced on a firm-fixed-price basis. This contract vehicle allows the VA to streamline acquisition of critical diagnostic equipment and supplies to meet the testing requirements of its medical programs, while leveraging Abbott's expertise as a leading provider of healthcare products to federal agencies.
The VA has issued several BPA call orders to Abbott under this agreement, with values ranging from $6,716 to $32,490. The call orders cover a variety of testing supplies and reagents, including blood gas and electrolyte analyzers, test cartridges, controls, and panels. These materials will be delivered to VA hospitals and clinics within the VA's Veterans Integrated Service Network 1 to enable their clinical testing operations. The contracts do not include any set-aside designations, reflecting Abbott's established capabilities in serving the federal healthcare market as a large business manufacturer.
Generated 9/7/24, 9:39 AM